Non-immunoglobulin E-mediated food allergy
- PMID: 39702412
- PMCID: PMC11656650
- DOI: 10.1186/s13223-024-00933-4
Non-immunoglobulin E-mediated food allergy
Abstract
Non-immunoglobulin E (IgE)-mediated food allergies are characterized by delayed gastrointestinal (GI) manifestations that occur after exposure to an inciting food protein; they include food protein-induced allergic proctocolitis (FPIAP), food protein-induced enteropathy (FPE), and food protein-induced enterocolitis syndrome (FPIES). Although the exact mechanisms underlying these disorders are not well understood, non-IgE-mediated food allergies likely represent a spectrum of disease with shared pathophysiological processes. Typically, these non-IgE-mediated food allergies begin in infancy or early childhood, although FPIES can present across the lifespan, with increasing reports in adults in recent years. Diagnosing non-IgE-mediated food allergies can be challenging due to the lack of noninvasive confirmatory tests or biomarkers for most of these disorders and the non-specific nature of GI symptoms. Thus, the diagnosis is usually made clinically, and relies on a constellation of typical symptoms that improve upon removal of the culprit food. The primary approach to management of FPIAP, FPE and FPIES is avoidance of the triggering food, and a multidisciplinary management approach that includes allergy/immunology may be required to avoid unnecessary food restriction and guide food reintroduction. This review outlines the clinical manifestations, epidemiology, pathophysiology, diagnosis, management, and prognosis of these non-IgE-mediated food allergies.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: Dr. Victoria E. Cook has participated in advisory boards and has received consulting fees and honoraria from Aralez/Miravo, CSL Behring, and ALK. Dr. Lori A. Connors has participated in advisory boards and has received consulting fees and honoraria from Astra Zeneca, GSK, Novartis and Sanofi. Dr. Timothy K. Vander Leek has participated in advisory boards and has received consulting fees and honoraria from Aralez/Miravo, Bausch Health, Covis Pharma and Pfizer. Dr. Wade Watson is medical advisor to Food Allergy Canada.
Figures
References
-
- Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, et al. Food allergy: a practice parameter update—2014. J Allergy Clin Immunol. 2014;134(5):1016–25. - PubMed
-
- Nowak-Węgrzyn A, Katz Y, Mehr SS, Koletzko S. Non-IgE-mediated gastrointestinal food allergy. J Allergy Clin Immunol. 2015;135(5):1114–24. - PubMed
-
- Caubet JC, Szajewska H, Shamir R, Nowak-Węgrzyn A. Non-IgE-mediated gastrointestinal food allergies in children. Pediatr Allergy Immunol. 2017;28(1):6–17. - PubMed
-
- Savilahti E. Food-Induced Malabsorption Syndromes. J Pediatr Gastroenterol Nutr. 2000;30:S61–S66. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
